top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
Autore Segelov Eva
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (144 p.)
Soggetto topico Medicine
Soggetto non controllato small bowel neuroendocrine tumours
pancreatic neuroendocrine tumours
liver metastases
midgut
meta-analysis
neuroendocrine tumors
carcinoid heart disease
carcinoid syndrome
somatostatin analogues
metastases
multidisciplinary
management
outcome
grading
staging
neuroendocrine neoplasms
chemotherapy
temozolomide
metronomic treatment
second-line
NOTCH
cancer-driven genes
mutational mechanism
germline mutations
small cell lung carcinoma
pancreatic NET
small bowel NET
medullary thyroid carcinoma
malignant castration-resistant prostatic cells
quality performance indicators
QPIs
cancer care
neuroendocrine tumour
NETs
modified Delphi
CommNETs
pancreatic neuroendocrine neoplasms
neuroendocrine tumor
long-term functional outcomes
pancreatectomy
diabetes mellitus
pancreatic exocrine insufficiency
body mass index
parenchyma-sparing surgery
neuroendocrine tumours
curative surgery
resection
follow-up
guidelines
relapse
recurrence
risk factor
mixed non-neuroendocrine neuroendocrine neoplasms
MiNENs
mixed adeno-neuroendocrine carcinoma
MANEC
2017 WHO classification
2019 WHO classification
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557692903321
Segelov Eva  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antitumoral Properties of Natural Products
Antitumoral Properties of Natural Products
Autore Fabiani Roberto
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (344 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato cytotoxic activity
NCI-60 cancer cell line
pristimerin
Salacia crassifolia
Celastraceae
Brazilian Cerrado biome
Salacia elliptica
Cheiloclinium cognatum
Plenckia populnea
Aspergillus fumigatus
Cordyceps sinensis
isochromanes
chiral resolution
ECD calculation
cytotoxicity
coronarin D
JNK
osteosarcoma
Zeylenone
gastric cancer
invasion
migration
apoptosis
anti-cancer agents
anthraquinones
glycosyltransferase
Dendrobium officinale
structure elucidation
anti-tumor activity
plantation mode
AR
Ganoderma tsugae
lipogenesis
prostate cancer
SREBP-1
ursolic acid
betulinic acid
triterpenoids
necrotic
quercetin
quercetagetin
patuletin
lichen
secondary metabolites
tumidulin
stemness potential
colorectal cancer cells
oncogene
transcriptional regulation
neferine
FAK/S6K1
autophagy
human neuroblastoma cells
natural yellow Monascus pigments
water-soluble
antioxidation
MCF-7 cells
phloretin
cell proliferation
inflammation
glucose uptake
Catalpa speciosa
Taxus cuspidata
Magnolia acuminata
phenols
antioxidants
anticancer
Colocasia esculenta
food bioactive
tarin
stable nanocapsules
entrapment efficiency
no-toxicity
preclinical tests
antitumoral activity
chemotherapeutic adjuvant
grape leaves
ASE
TP
Antioxidant activities
Antiproliferative
pro-apoptotic effects
Gene expression
Nutraceuticals
Cucurbitacin B
gefitinib-resistant NSCLC
EGFR
lysosomal degradation
CIP2A
zerumbone
cancer
NF-κB
IL-6/JAK2/STAT3
Akt
FOXO1
multiple myeloma
quality control
naringenin
flavonoids
traditional preparation
cancer stem cells
phytochemicals
plant-derived foods
fruit
vegetable
cell signaling
Artemisia absinthium
endoplasmic reticulum stress
mitochondrial-dependent pathway
melanoma
bee venom
melittin
temozolomide
AKT
MAPK
antrodin C
mTOR
metabolic stability
capsazepine
inflammatory diseases
ROS
TRPV1
PI3K/AKT/mTOR
CLE-10
LC3
MDA-MB-231
lactoferrin hydrolysate
copper
manganese
gastric cancer cells
anti-cancer activity
molecular mechanism
natural product alkaloids
cephalotaxine
protein synthesis inhibition
antiproliferation agents
folk medicine
DLD-1 cells
doxorubicin
chemotherapy
drug resistance
CrataBL
glioblastoma
mesenchymal stem cells
microenvironment
plant lectin
protease inhibitor
cryptolepine
neocryptolepine
isocryptolepine
antiproliferative activity
structure activity relationships
Licochalcone A
ATM-Chk2
13-ethylberberine
mitochondrial ROS
RT-R breast cancer cells
diallyl disulfide
PI3K/Akt/mTOR pathway
Pulsatilla saponin D
SB365
glioblastoma multiforme
autophagic flux inhibition
lysosomal membrane permeabilization
mitochondrial membrane potential
CLEFMA
p38
proanthocyanins
TNF-α
lung adenocarcinoma
natural compounds
cervical cancer
cell cycle arrest
dicentrine
metastasis
glioma
semi-synthetic derivative
ingenol
Euphorbia tirucalli
protein kinase C
seaweed
porphyran
carrageenan
anti-cancer
natural products
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557419703321
Fabiani Roberto  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antitumoral Properties of Natural Products : Volume 2
Antitumoral Properties of Natural Products : Volume 2
Autore Fabiani Roberto
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (300 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato cytotoxic activity
NCI-60 cancer cell line
pristimerin
Salacia crassifolia
Celastraceae
Brazilian Cerrado biome
Salacia elliptica
Cheiloclinium cognatum
Plenckia populnea
Aspergillus fumigatus
Cordyceps sinensis
isochromanes
chiral resolution
ECD calculation
cytotoxicity
coronarin D
JNK
osteosarcoma
Zeylenone
gastric cancer
invasion
migration
apoptosis
anti-cancer agents
anthraquinones
glycosyltransferase
Dendrobium officinale
structure elucidation
anti-tumor activity
plantation mode
AR
Ganoderma tsugae
lipogenesis
prostate cancer
SREBP-1
ursolic acid
betulinic acid
triterpenoids
necrotic
quercetin
quercetagetin
patuletin
lichen
secondary metabolites
tumidulin
stemness potential
colorectal cancer cells
oncogene
transcriptional regulation
neferine
FAK/S6K1
autophagy
human neuroblastoma cells
natural yellow Monascus pigments
water-soluble
antioxidation
MCF-7 cells
phloretin
cell proliferation
inflammation
glucose uptake
Catalpa speciosa
Taxus cuspidata
Magnolia acuminata
phenols
antioxidants
anticancer
Colocasia esculenta
food bioactive
tarin
stable nanocapsules
entrapment efficiency
no-toxicity
preclinical tests
antitumoral activity
chemotherapeutic adjuvant
grape leaves
ASE
TP
Antioxidant activities
Antiproliferative
pro-apoptotic effects
Gene expression
Nutraceuticals
Cucurbitacin B
gefitinib-resistant NSCLC
EGFR
lysosomal degradation
CIP2A
zerumbone
cancer
NF-κB
IL-6/JAK2/STAT3
Akt
FOXO1
multiple myeloma
quality control
naringenin
flavonoids
traditional preparation
cancer stem cells
phytochemicals
plant-derived foods
fruit
vegetable
cell signaling
Artemisia absinthium
endoplasmic reticulum stress
mitochondrial-dependent pathway
melanoma
bee venom
melittin
temozolomide
AKT
MAPK
antrodin C
mTOR
metabolic stability
capsazepine
inflammatory diseases
ROS
TRPV1
PI3K/AKT/mTOR
CLE-10
LC3
MDA-MB-231
lactoferrin hydrolysate
copper
manganese
gastric cancer cells
anti-cancer activity
molecular mechanism
natural product alkaloids
cephalotaxine
protein synthesis inhibition
antiproliferation agents
folk medicine
DLD-1 cells
doxorubicin
chemotherapy
drug resistance
CrataBL
glioblastoma
mesenchymal stem cells
microenvironment
plant lectin
protease inhibitor
cryptolepine
neocryptolepine
isocryptolepine
antiproliferative activity
structure activity relationships
Licochalcone A
ATM-Chk2
13-ethylberberine
mitochondrial ROS
RT-R breast cancer cells
diallyl disulfide
PI3K/Akt/mTOR pathway
Pulsatilla saponin D
SB365
glioblastoma multiforme
autophagic flux inhibition
lysosomal membrane permeabilization
mitochondrial membrane potential
CLEFMA
p38
proanthocyanins
TNF-α
lung adenocarcinoma
natural compounds
cervical cancer
cell cycle arrest
dicentrine
metastasis
glioma
semi-synthetic derivative
ingenol
Euphorbia tirucalli
protein kinase C
seaweed
porphyran
carrageenan
anti-cancer
natural products
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Antitumoral Properties of Natural Products
Record Nr. UNINA-9910557531303321
Fabiani Roberto  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Treatment Strategies for Glioblastoma
Novel Treatment Strategies for Glioblastoma
Autore Stylli Stanley
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (268 p.)
Soggetto topico Medicine
Soggetto non controllato glioblastoma
glioma
temozolomide
radiotherapy
immunotherapy
novel therapy
personalized treatment
drug repurposing
invasion
invadopodia
ion channels
gene therapy
viral vectors
brain tumor
nanomedicine
cancer stem cell
targeted therapy
brain cancer
cell cycle
differentiation
proliferation
RAS
SRGAP2
stem cell
TP53
glioblastoma multiforme
GBM
nerve/glial antigen 2
NG2
CK2
CX-4945
migration
CRISPR/Cas9
anticancer
anti-angiogenesis
thyrointegrin αvβ3
PEG
triazole tetrac
P-bi-TAT
P-m-TAT
tetrac
one-carbon metabolism
de novo purine synthesis
metabolic reprogramming
metabolic treatment
vaccine
immune checkpoint inhibitors
chimeric antigen receptor (CAR) T cells
glioblastoma (GB)
prolyl-oligopeptidase (POP)
vascular endothelial growth factor (VEGF)
transforming growth factor-β (TGF-β)
angiopoietin (Ang)
endothelial nitric oxide synthase (eNOS)
newly diagnosed glioblastoma
recurrent glioblastoma
new trial design
drug-inducible gene expression
Mardepodect
Regorafenib
drug targets
tumor antigens
renin-angiotensin system
pluripotent stem cells
organoids
cancer stem cells
cancer stem cell niche
tumor microenvironment
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557363703321
Stylli Stanley  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of miRNAs in Cancer : Analysis of Their Targetome
Role of miRNAs in Cancer : Analysis of Their Targetome
Autore Navarro Alfons
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (302 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato miR526b
miR655
breast cancer
angiogenesis
lymphangiogenesis
EP4
PI3K/Akt
microRNA-361
EMT
tumor microenvironment
cancer diagnosis
cancer treatment
Bladder cancer
microRNA
genetic marker
progression
ccRCC
prognostic biomarker
miRNA
transcription factor
interplay
microRNAs
exosomes
liquid biopsy
metastasis
cancer
liquid biopsies
tumor
SNAIL (SNAI1) transcription factor
epithelial to mesenchymal transition (EMT)
long non-coding RNAs (lncRNAs)
circular RNAs
viral miRNAs
EBV
HHV-8
HPV
HCV
HBV
MCPyV
glioblastoma
MGMT
survival
radiotherapy
chemotherapy
temozolomide
translational medicine
oncomiRNA
post-transcriptional regulation
immune regulation
adrenocortical carcinoma
micro RNA
non-coding RNA
thyroid carcinoma
radioactive iodine
drug resistance
prognosis
Burkitt lymphoma
miR-378a-3p
cell growth
pancreatic cancer
radioresistance
personalized medicine
biomarker
target
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Role of miRNAs in Cancer
Record Nr. UNINA-9910566464803321
Navarro Alfons  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui